For the gift, start research and development of graphene batteries

Chapter 136 Breakthrough Achievements
In the Xia Medical Group conference room, a new round of project meetings will be held again.

The main purpose of this meeting is to summarize the previous experiments.

According to Sun Mengqing, this experiment has achieved key results, laying the foundation for subsequent research.

"The spirit-chasing project, according to our experiments, the concept of using the spirit-chasing pill as the base, the core protein as the target, and the Peiyuan pill as the tool is completely feasible. The spirit-chasing project has achieved groundbreaking results."

Sun Mengqing concluded.

After saying this, the audience erupted.

Research on anti-tumor drugs has always been a key scientific research project of Xiayi Group.

Compared with the targeted drugs that have been successfully studied before, there is a big difference.

The current research ideas are more like targeted drugs.

Everyone doubts whether the anti-tumor drugs studied in this way can kill all tumor cells at once.

If this is the case, then the disease of malignant tumors will become history.

Everyone is an industry insider, well aware of the huge influence of this anti-tumor drug.

Even this kind of research and development idea is the first in the industry.

"According to our previous screening, there are a total of [-] surface proteins on gastric cancer tumor cells, which have the potential to identify characteristics. The drugs studied for these characteristic proteins have been identified and found to have the characteristics of three surface proteins, which are very strong."

"This means that these three drugs have strong recognition for gastric cancer tumor cells."

Sun Mengqing concluded.

Hearing Sun Mengting's words, Jiang Ming also heaved a sigh of relief.

He didn't expect to find three kinds, which was beyond Jiang Ming's expectation.

Of course, in fact, what Jiang Ming didn't know was that there are many specific surface proteins, and they selected these three after thousands of selections.

These three types are relatively perfect in all aspects and the most targeted.

Of course, the treatment of gastric cancer cells may not be treated by a single drug. If there are three types, it is of great significance for the development of anti-tumor drugs.

After all, not everyone is suitable for the same drug.

In addition, some patients have immune tolerance to drugs, and there are three specific proteins that can be used as targets, which must be very effective.

"Are you going to pool the three specificities, or develop three drugs?"

Jiang Ming asked.

"At present, it has not been decided yet, and we are still waiting to determine the follow-up direction."

Sun Mengqing said.

"However, according to the engineer's idea, if three drugs can be developed, it should be good."

Sun Mengqing added.

Uh.
Hearing Sun Mengqing's words, Jiang Ming was noncommittal.

According to Jiang Ming's understanding, it would be best if a drug that could recognize three surface proteins at the same time could be developed.

But the difficulty in the middle will be very great.

Of course, the more important thing is that Jiang Ming doesn't know how high a surface protein is recognized.

Whether to perform three types of identification at the same time.

Recognition of a surface protein will identify all tumor cells.However, a single identification is likely to cause over-recognition and cause accidental injury.

After all, tumor cells are the normal cells of the human body, and they just proliferate uncontrollably.

Thinking of this, Jiang Ming asked:
"Are there any statistics, how high is the recognition rate of a single characteristic protein?"

"About 80% or so."

Sun Mengqing said.

Hearing that Sun Mengqing had an 80% recognition rate, the people at the scene were all excited.

You know, according to past experience, a drug with a tumor recognition rate of more than 40% is considered a relatively successful drug.

More than 50% of them are in the industry, even if the drugs with more outstanding effects are compared.

In the spirit chasing project, the recognition rate exceeds 80%, which is a bit scary.

Of course, such a high degree of recognition is not necessarily a good thing.

Although the degree of recognition is high, it also faces the problem of over-recognition.

It is a cell that is not a problem in itself, but is recognized by the drug and then killed.

The occurrence of this situation will cause a large amount of damage to normal cells.In turn, the normal functions of the body are damaged, which means killing one thousand enemies and self-defeating eight hundred.

Of course, despite this situation, high recognition is still extremely advantageous.

Jiang Ming was also thinking about this issue. At present, it seems that the degree of recognition is almost the same.

The 80% recognition degree represents the recognition degree of one-time medication.

80% of the tumor cells will be identified at one time, and then the remaining 20% ​​will be identified when the drug is administered next time.

Presumably, after several courses of treatment, the tumor cells in the body must have been quickly eliminated to an extremely small level.

Coupled with the cooperation of the human immune system, great achievements will be made in the fight against tumors.

As for whether malignant tumors can be treated thoroughly, it depends on the ability of each person's immune system.

"How to solve the situation of misidentification, or the side effects of drugs?"

Jiang Ming raised this difficult question.

Hearing Jiang Ming's words, the scene fell silent instantly.

Everyone is also aware of this problem, and after solving this problem, it will be a successful drug.

"About this issue, we will study it in the future."

As the project manager, Sun Mengqing saw that no one responded, so she could only speak.

Hearing Sun Mengqing's words, Jiang Ming didn't speak for a long time, and finally, he opened his mouth and said:
"The recognition rate of 80% is a bit high, and there is still a lot of room for decline."

Sun Mengqing:? ? ?

Engineer present: ? ? ?
Everyone was guessing what Jiang Ming meant by this.Some people think that the recognition rate is high, and there is still room for decline?No need!

"Boss Jiang, can you elaborate?"

Sun Mengqing asked.

"To solve the problem of misidentification, it is very simple."

Jiang Ming said.

After hearing Jiang Ming's words, the scene was completely silent, waiting for Jiang Ming's next words.

"At present, there are three surface proteins, and it is recommended to recognize the three surface proteins at the same time, and only those that match are targeted."

Jiang Ming said.

"However, if three surface proteins are recognized at the same time, will the recognition degree drop a lot?"

An engineer said so.

"So, you need to study this."

"The best solution is to recognize all three surface proteins, and it doesn't matter if the recognition rate is reduced."

After hearing Jiang Ming's words, Sun Mengqing understood, and then recorded the follow-up research ideas.

"In addition, the fusion of therapeutic drugs should also be carried out simultaneously. In the case of fusion, a single surface protein can be used to recognize the drug, and then fused again, finally reaching three levels."

Jiang Ming said.

"understand!"

Now that the meeting is over, the project will be over, and Sun Mengqing will convene relevant departments to carry out follow-up research as required.

When Jiang Minghui held a project meeting with Sun Mengqing, the general manager's office of Xia Medical Group.

Shi Meisheng looked at the newspaper in his hand with a gloomy expression.

Because of unknown reasons, someone reported two anti-tumor cases before Xia Medical Group stopped research and development.

Xia Medical Group, previously developed two anti-tumor drugs simultaneously: Meiling and Xiaopin.

These two drugs have been developed by Xia Medical Group for three years, and they were at a critical time before.

However, due to Jiang Ming's three projects, the research and development resources were insufficient. Therefore, Xia Medical Group stopped the research of these two anti-tumor drugs.

Put most of your energy into these three projects.

Originally, this was very confidential information, but somehow it was leaked and reported.

As Xia Guo's leader in the research and development of anti-tumor drugs, this explosive project immediately caused waves in the market once it was reported.

Of course, the good news is that according to news reports, it is only known that Xiayi Group has stopped research and development, but why it stopped is unknown.

From this point of view, the person who broke the news should not be very high in the Xia Medical Group.

Otherwise, it is impossible not to know that it is because of new and more important projects that the development of these two drugs has been stopped.

It is estimated that in their minds, these two drugs should have encountered major technical difficulties, and this kind of speculation is relatively normal.

Of course, Shi Meisheng also agrees with stopping the research and development of these two projects.

After all, among the new projects, there are anti-tumor drugs.The two sides overlap, and there is no need for parallel research and development.

Moreover, I heard that anti-tumor drugs have made great achievements.This proves that Xia Medical Group's previous decision was very correct.

It's just the internal situation of Xia Medical Group, they know it.

But how to explain it to investors has to be considered.

After all, Xia Medical Group is a listed company and must still abide by market rules.

In principle, Xia Medical Group should respond publicly to such major news.

Thinking of this, Shi Meisheng called Jiang Ming and Sun Mengqing to the office to have a look at the progress of the project, and then to see from the perspective of the project, what countermeasures are there.

It was just a random question, and Shi Meisheng didn't expect any results. Who would have thought that the news he got was simply shocking.

"What, there is a breakthrough result? There is no problem with the research direction, and it is only a matter of time before the research is completed? Is this research method a groundbreaking result?"

Shi Meisheng was also a little shocked when he heard Sun Mengqing's words.

Although he knew that Jiang Ming was not easy and the importance of these three projects, Shi Meisheng never thought that such a big achievement would be achieved in only half a year.

You know, generally this kind of anti-tumor drug is taken in units of several years, and it has achieved results in such a short period of time, and it is a breakthrough result. Shi Meisheng can't believe it.

This is actually a bit surprising!

And it was an innovative way. All kinds of words came out of Sun Mengqing's mouth, but they seemed unreal.

"Mr. Shi, yes, the spirit chasing project has made significant progress."

"This is a summary of the recent work of our project team."

While talking, Sun Mengqing handed the printed materials to Shi Meisheng.

It can be seen that Sun Mengqing's work is well prepared.Obviously, he has been in frequent contact with Shi Meisheng and knows Shi Meisheng's style of doing things.

Shi Meisheng took the documents and looked through them carefully.

After looking through it, Shi Meisheng confirmed that the spirit chasing project had indeed achieved great results.

Although the final drug has not yet been successfully researched, this research method and this concept are extraordinary.

As the general manager of Xia Medical Group, he is relatively clear about drug research and development.

According to the data, if the anti-tumor drug for gastric cancer can be successfully developed, it is equivalent to CSPC, which has mastered a set of technical routes for continuously developing various anti-tumor drugs.

This is a platform, a general drug development platform.

Shi Meisheng knew the value of it.

Combined with the rumors about Xia Medical Group from the outside world, Shi Meisheng knew that it was time to show something to the outside world.

Many people in Xia Kingdom advertise that foreign things are always the best.

They turn a blind eye to the advantages of their own products, but keep looking for shortcomings.

This phenomenon of xenophobia has become more and more serious in recent years.

A country, a nation, if the people don't have a sense of pride in being in it, and don't have the spirit of going forward and not regretting failures, then the country has no backbone.

Even if it can rise, it has nothing to do with ordinary people.

Thinking of this, Shi Meisheng felt that he should take advantage of this opportunity to spread the word.

It's just that whether this will involve leaking secrets needs to be carefully considered.

You should know that these three projects are all confidential projects. In principle, without the consent of the Bureau of Secrecy, no one has the right to disclose information to the outside world.

Fortunately, the suspension of research and development of anti-tumor drugs this time did not involve any leaks involving the three projects.

If it really leaked out, I believe that the Bureau of Secrecy will dig three feet into the ground and dig out the other party.

Thinking of this, Shi Meisheng told Jiang Ming and Sun Mengqing that he already knew the situation.Two people are required to speed up the research progress, and strive to make the project research successful in the shortest time.

Immediately, Shi Meisheng reported the news about the spirit chasing project and waited for approval from the Secrecy Bureau.

Shi Meisheng originally thought that the disclosure of this external information might take a long time for approval.

But one day later, Shi Meisheng received an approval to disclose to a certain extent.

Shi Meisheng was also amazed at this efficiency and could only lament that he was so lucky this time.

Of course, in fact, after receiving Shi Meisheng's application, the people from the Secrecy Bureau immediately forwarded the relevant request to the Ministry of Science and Technology.

Then colleagues from the Science and Technology Department transferred it to Long Zhiwei.

Just like that, after going round and round, it was Long Zhiwei who finally conducted the review.

Seeing Shi Meisheng's application materials and looking at the content in the attachment, Long Zhiwei couldn't help feeling after reading that Jiang Ming still gave people as many surprises as ever.

How long has it been since the research on anti-tumor drugs has reached this level.

If you give me some more time, it will be fine.

However, although the progress of anti-tumor drugs is very smooth and the results are outstanding, Long Zhiwei feels that none of them are as important as Peiyuan Dan.

This kind of drug for treating tumors is itself a market-oriented application.

Logically, they shouldn't be involved.

But this time, all three projects were set as confidential projects to consider the role of Peiyuan Dan in them.

In addition, it is also considered to hide Jiang Ming behind the scenes, at least Long Zhiwei is not going to push Jiang Ming to the foreground until the project is completely successful.

After all, with the title of the father of carbon-based batteries, it is better not to add too much honor to Jiang Ming in a short time.

(End of this chapter)